Loading viewer...
report
Format: PDF report
This report presents primary results from a Phase 1 study of Antolimab, an investigational antibody for treating chronic gastrointestinal symptoms linked to mast cells.
presentation
report
888 Holdings plc
report
BAMKO
report
Boscov's
report
Fitch